Kiniksa Pharmaceuticals International (KNSA) Inventory (2021 - 2026)

Kiniksa Pharmaceuticals International has reported Inventory for 6 years, with the latest figure at $73.1 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 231.42% year-over-year to $73.1 million; the trailing twelve-month figure through Mar 2026 stood at $73.1 million (up 231.42% YoY), and the FY2025 full-year result was $54.9 million, up 108.22% from the prior year.
• Inventory for Q1 2026 stood at $73.1 million, up from $54.9 million in the prior quarter.
• The five-year high for Inventory was $73.1 million in Q1 2026, with the low at $13.2 million in Q1 2022.
• Historically, Inventory has averaged $31.2 million across 5 years, with a median of $26.4 million in 2024.
• Annual changes were most pronounced in 2022 — Inventory soared 504.07% — and 2025, when it slipped 19.1%.
• Kiniksa Pharmaceuticals International's Inventory stood at $21.6 million in 2022, then soared by 44.09% to $31.1 million in 2023, then fell by 15.29% to $26.4 million in 2024, then soared by 108.22% to $54.9 million in 2025, then surged by 33.24% to $73.1 million in 2026.
• The last three Inventory figures came in at $73.1 million (Q1 2026), $54.9 million (Q4 2025), and $41.4 million (Q3 2025), per Business Quant data.